SHSE:603520 (China)
Â
Class A
Â¥
7.96
(+0.89%)
Aug 26
New Key Statistics Module, Z-Score and F-Score
SHSE:603520 Key Ratios
Market Cap ¥ M | 3,489.74 |
Enterprise Value ¥ M | 5,232.42 |
P/E(ttm) | 84.68 |
PE Ratio without NRI | 46.82 |
Forward PE Ratio | 13.84 |
Price/Book | 1.29 |
Price/Sales | 1.12 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,442.00 |
EPS (TTM) ¥ | 0.09 |
Beneish M-Score | -2.51 |
10-y EBITDA Growth Rate % | 6.50 |
5-y EBITDA Growth Rate % | -4.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 37.02 |
EV-to-EBITDA | 37.02 |
PEG | -- |
Shares Outstanding M | 438.41 |
Net Margin (%) | 1.30 |
Operating Margin % | 8.28 |
Pre-tax Margin (%) | 1.63 |
Quick Ratio | 0.65 |
Current Ratio | 1.00 |
ROA % (ttm) | 0.57 |
ROE % (ttm) | 1.64 |
ROIC % (ttm) | 2.93 |
Dividend Yield % | -- |
Altman Z-Score | 1.18 |
SHSE:603520 Number of Guru Trades
SHSE:603520 Volume of Guru Trades
Gurus Latest Trades with SHSE:603520
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603520 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Starry Pharmaceutical Co Ltd Insider Transactions
No Available Data